T1	Participants 606 837	Pregnant women with WHO stage 1, 2, or 3 HIV-1 infection who had CD4 cell counts of 200-500 cells per Î¼L were enrolled at five study sites in Burkina Faso, Kenya, and South Africa to start study treatment at 28-36 weeks' gestation.
T2	Participants 1998 2055	From June, 2005, to August, 2008, 882 women were enrolled
